Treo effervescent tablet

Treo is a well-known effervescent pain relief medication primarily marketed in the Nordic region. The brand was originally developed naturally within the regional pharmaceutical landscape to provide fast-acting relief for headaches and migraines using a combination of acetylsalicylic acid and caffeine. In the Swedish market, Treo has become a household name for effervescent analgesics.

Manufacturing typically takes place in Denmark, where specialized facilities handle the production of effervescent tablets. The brand is currently owned by Viatris Inc., a global healthcare company formed through the merger of Mylan and Pfizer's Upjohn division. Viatris maintains the brand's strong presence in Northern Europe through their local subsidiaries and distribution networks.